The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Moderna Inc shares valued at $21,363 were sold by Hoge Stephen on Aug 12 ’24. At $84.10 per share, Hoge Stephen sold 254 shares. The insider’s holdings dropped to 1,442,357 shares worth approximately $118.63 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hoge Stephen purchased 254 shares, netting a total of over 21,363 in proceeds.
Before that, AFEYAN NOUBAR had sold 15,000 shares from its account. In a trade valued at $1,799,443, the Director traded Moderna Inc shares for $119.96 each. Upon closing the transaction, the insider’s holdings decreased to 15,000 shares, worth approximately $182.93 million.
As published in a research note from Deutsche Bank on August 07, 2024, Moderna Inc [MRNA] has been rated up from a Sell to a Hold and the price target has been revised to $80 from $85. Analysts at RBC Capital Mkts downgraded the stock from ‘”an Outperform”‘ to ‘”a Sector perform”‘ outlook in a report released in early August. As of February 26, 2024, HSBC Securities has decreased its “Hold” rating to a “Reduce” for MRNA. Earlier on January 02, 2024, Oppenheimer upgraded its rating. Their new recommendation was “an Outperform” for MRNA stock which previously was a “a Perform”.
Analyzing MRNA Stock Performance
During the last five days, there has been a surge of approximately 0.86%. Over the course of the year, Moderna Inc shares have dropped approximately -17.30%. Shares of the company reached a 52-week high of $170.47 on 05/24/24 and a 52-week low of $78.07 on 08/05/24. A 50-day SMA is recorded $119.90, while a 200-day SMA reached $105.70. Nevertheless, trading volume fell to 2.63 million shares from 3.07 million shares the previous day.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 81.23, which, if violated, would cause prices to drop to 80.20. In the upper region, resistance lies at 83.40. The next price resistance is at 84.54. RSI (Relative Strength Index) is 23.79 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -12.59, which suggests the price will decrease in the coming days. Percent R is at 91.22%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
